Erratum: LAMA4 upregulation is associated with high liver metastasis potential and poor survival outcome of pancreatic cancer: Erratum (Theranostics (2020) 10:22 (10274-10289) DOI: 10.7150/thno.47001)

Biao Zheng, Jianhua Qu, Kenoki Ohuchida, Haimin Feng, Stephen Jun Fei Chong, Zilong Yan, Yicui Piao, Peng Liu, Nan Sheng, Daiki Eguchi, Takao Ohtsuka, Kazuhiro Mizumoto, Zhong Liu, Shazib Pervaiz, Peng Gong, Masafumi Nakamura

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the original Figure 6C of our article [1], we mistakenly repeatedly used the LAMA4 shRNA-1 knockdown figure (Figure 6C, bottom middle) as the LAMA4 shRNA-2 knockdown figure (Figure 6C, bottom right) in the cell migration assay of CAFs. The Figure 6C should be corrected as follows. The figure corrected in this erratum does not influence any original conclusions in our study. We apologize for any inconvenience or misunderstanding that this error may have caused.

Original languageEnglish
Pages (from-to)10171-10172
Number of pages2
JournalTheranostics
Volume11
Issue number20
DOIs
Publication statusPublished - 2021

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Fingerprint

Dive into the research topics of 'Erratum: LAMA4 upregulation is associated with high liver metastasis potential and poor survival outcome of pancreatic cancer: Erratum (Theranostics (2020) 10:22 (10274-10289) DOI: 10.7150/thno.47001)'. Together they form a unique fingerprint.

Cite this